Com-COV study supports flexible priming intervals in standard/mixed schedules

Published on June 8, 2022

Researchers running the University of Oxford-led Com-COV study have reported the results of a study assessing the immune response and reactogenicity of two-dose vaccine schedules when administered at four-week and 12-week intervals, using the Oxford-AstraZeneca or Pfizer-BioNTech vaccines. 
Continue reading on website
Other news

Gravity-defying spike waves rewrite the rule book

June 8, 2022
Researchers studying wave breaking have found that axisymmetric ‘spike waves’ can far exceed limits that were previously thought to dictate the maximum height of ocean waves.

Multiple heart-related conditions linked to triple dementia risk regardless of genetics

June 8, 2022
Having multiple conditions that affect the heart are linked to a greater risk of dementia than having high genetic risk, according to a largescale new study co-led by the University of Oxford.